New patent for Msd Sub drug ISENTRESS

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for ISENTRESS
Annual Drug Patent Expirations for ISENTRESS

Isentress is a drug marketed by Msd Sub Merck and is included in three NDAs. It is available from eight suppliers. There are six patents protecting this drug and one Paragraph IV challenge.

ISENTRESS drug price trends.

The generic ingredient in ISENTRESS is raltegravir potassium. Eight suppliers are listed for this compound. Additional details are available on the raltegravir potassium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top